国: イスラエル
言語: 英語
ソース: Ministry of Health
LEVONORGESTREL
CTS LTD
G03AC03
TABLETS
LEVONORGESTREL 1.5 MG
PER OS
Not required
LABORATOIRE HRA PHARMA , FRANCE
LEVONORGESTREL
LEVONORGESTREL
Emergency contraceptive.
2015-05-31
1 PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed without a doctor’s prescription NORLEVO 1.5 MG Tablets The active ingredient and its quantity: The tablet contains: Levonorgestrel 1.5 mg. For the inactive ingredients and allergens - see the paragraph in Section 2 “Important information about some of the ingredients of the medicine” and Section 6 “Further Information”. The medicine is dispensed without a prescription for women and girls over 14 years old. For girls less than 14 years old, the medicine is dispensed with a doctor's prescription only. If you have started treatment without consultation, refer to your doctor as soon as possible. Read the leaflet carefully in its entirety before using the medicine. This leaflet contains concise information about the medicine. If you have further questions, refer to the doctor or pharmacist. You must take the medication according to all the instructions in the dosage section of this leaflet. Consult a pharmacist if you need more information. 1. WHAT IS THE MEDICINE INTENDED FOR? NorLevo is intended for preventing pregnancy up to 72 hours (3 days) after having unplanned, unprotected intercourse or after rape, or when there is concern that the contraceptives used are insufficient. Therapeutic group: Progestogens (female hormones). The medicine is intended as an emergency contraceptive when taken up to 72 hours (3 days) after having unprotected intercourse, or if your routine contraceptive methods have failed. NorLevo contains a synthetic hormone called levonorgestrel. NorLevo prevents pregnancy in 99% of the situations when it is taken within 72 hours from the date of unprotected intercourse. Patient Safety Information Card: In addition to the leaflet, NorLevo has a patient safety information card. This card contains important safety information that you should be aware of and follow before and after taking NorLevo. Refer to the patient safety information card and the patient leaflet befo 完全なドキュメントを読む